Characterization/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
enhancer-binding/JJ
proteins/NNS
from/IN
the/DT
human/JJ
T-cell/NN
line/NN
Jurkat/NN
./.

The/DT
transcription/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV-1/NN
)/)
is/VBZ
under/IN
the/DT
control/NN
of/IN
cellular/JJ
proteins/NNS
that/WDT
bind/VBP
to/TO
the/DT
viral/JJ
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
./.
=====
Among/IN
the/DT
protein-binding/JJ
regions/NNS
of/IN
the/DT
HIV-1/NN
LTR/NN
is/VBZ
the/DT
transcription-enhancer/JJ
region/NN
./.
=====
We/PRP
show/VBP
that/IN
at/IN
least/JJS
one/CD
inducible/JJ
,/,
C1/NN
,/,
and/CC
one/CD
constitutive/JJ
,/,
C2/NN
,/,
protein/NN
can/MD
bind/VB
to/TO
the/DT
HIV/NN
enhancer/NN
in/IN
Jurkat/NN
cells/NNS
./.
=====
The/DT
two/CD
proteins/NNS
differ/VBP
in/IN
their/PRP$
surface/NN
charge/NN
,/,
since/IN
they/PRP
are/VBP
separable/JJ
by/IN
anion-exchange/JJ
chromatography/NN
./.
=====
Bivalent/JJ
cations/NNS
such/JJ
as/IN
Mg2+/NN
and/CC
Zn2+/NN
differentially/RB
affect/VBP
their/PRP$
binding/NN
to/TO
oligonucleotides/NNS
which/WDT
contain/VBP
the/DT
HIV-enhancer/NN
domain/NN
./.
=====
Both/CC
C1/NN
and/CC
C2/NN
proteins/NNS
also/RB
bind/VBP
to/TO
a/DT
similar/JJ
sequence/NN
found/VBN
in/IN
the/DT
interleukin-2-receptor/NN
alpha-subunit/NN
enhancer/NN
./.
=====
The/DT
inducible/JJ
C1/NN
protein/NN
was/VBD
partially/RB
purified/VBN
by/IN
three/CD
chromatographic/JJ
steps/NNS
and/CC
characterized/VBN
by/IN
u.v./NN
cross-linking/NN
as/IN
a/DT
47/CD
kDa/NN
protein/NN
./.